Each CRISPR/Cas9 Knockout (KO) Plasmid product consists of a pool of 3 plasmids designed to ensure identification and cleavage of a specific gene for maximum knockout efficiency. Each plasmid encodes a unique 20 nt sequence derived from the GeCKO (v2) library.
CLN3 CRISPR Plasmids (m)
- Target species: mouse; for corresponding human product, see CLN3 CRISPR Plasmids (h)
- CRISPR/Cas9 KO Plasmids consists of CLN3-specific 20 nt guide RNA sequences derived from the GeCKO (v2) library
- For CRISPR gene knockout, gRNA sequences direct the Cas9 protein to induce a site-specific double strand break (DSB) in the genomic DNA
- Target-specific CRISPR Plasmids for both gene knockout and activation are available. Please refer to the detailed product information in the tabs below
- Gene knockdown or activation can be assayed using CLN3 Antibody (C-1): sc-398192
- All products are provided as transfection-ready, purified plasmid DNA, except the Lentiviral Activation Particles which have been prepackaged as Lentiviral Particles for use with hard-to-transfect cells
QUICK LINKS
Ordering Information
CRISPR/Cas9 KO Plasmid
Double Nickase Plasmids
CRISPR Activation Plasmids
Lentiviral Activation Particles
Recommended Control Products
SEE ALSO...
Cln3 Antibodies for analysis of cellular responses to Cln3 CRISPR Products
Learn more about the CRISPR System
CRISPR/Cas9 KO plasmids, Double Nickase Plasmids and CRISPR/dCas9 Activation plasmids are considered a "Licensed Product" and are to be used in accordance with the Limited/Label License. Click here for details
Description
See Protocol Online.
QUICK LINKS
Related Products
Description
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- CLN3 Double Nickase Plasmid (m) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- The paired gRNAs encoded by CLN3 Double Nickase Plasmid (m2) differ from the paired gRNAs in CLN3 Double Nickase Plasmid (m)
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: CLN3 Antibody (C-1): sc-398192
See Protocol Online.
DOWNLOADS
QUICK LINKS
Related Products
Description
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- CLN3 CRISPR Activation Plasmid (m) is a synergistic activation mediator (SAM) transcription activation system designed to specifically upregulate gene expression
- CLN3 CRISPR Activation Plasmid (m) consists of three plasmids at a 1:1:1 mass ratio: a plasmid encoding the deactivated Cas9 (dCas9) nuclease (D10A and N863A) fused to the transactivation domain VP64, and a blasticidin resistance gene; a plasmid encoding the MS2-p65-HSF1 fusion protein, and a hygromycin resistance gene; a plasmid encoding a target-specific 20 nt guide RNA fused to two MS2 RNA aptamers, and a puromycin resistance gene
- The resulting SAM complex binds to a site-specific region approximately 200-250 nt upstream of the transcriptional start site and provides robust recruitment of transcription factors for highly efficient gene activation
- Following transfection, gene activation efficiency can be assayed by WB, IF or IHC using antibody: CLN3 Antibody (C-1): sc-398192
See Protocol Online.
DOWNLOADS
QUICK LINKS
Related Products
Description
- 200 µl of transduction-ready, high-titer CRISPR/dCas9 Lentiviral Activation Particles
- CLN3 Lentiviral Activation Particles (m) is a synergistic activation mediator (SAM) transcription activation system designed to specifically and efficiently upregulate gene expression via lentiviral transduction of cells
- CLN3 Lentiviral Activation Particles (m) contain the following SAM Activation elements: a deactivated Cas9 (dCas9) nuclease (D10A and N863A) fused to the transactivation domain VP64, an MS2-p65-HSF1 fusion protein and a target-specific 20 nt. guide RNA. They also contain the blasticidin, hygromycin and puromycin resistance genes
- Upon transduction, the SAM complex binds to a site-specific region approximately 200-250 nt. upstream of the transcriptional start site and provides robust recruitment of transcription factors for highly efficient gene activation
- The guide RNA in the CLN3 Lentiviral Activation Particles (m2) encodes a target-specific 20 nt guide RNA that differs from the guide RNA in CLN3 Lentiviral Activation Particles (m)
- Following transfection, gene activation efficiency can be assayed by WB, IF or IHC using antibody: CLN3 Antibody (C-1): sc-398192
See Protocol Online.
DOWNLOADS
QUICK LINKS
Related Products
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CLN3 CRISPR/Cas9 KO Plasmid (m2) | sc-419692-KO-2 | 20 µg | $397.00 | |||
CLN3 HDR Plasmid (m2) | sc-419692-HDR-2 | 20 µg | $445.00 | |||
CLN3 Double Nickase Plasmid (m) | sc-419692-NIC | 20 µg | $410.00 | |||
| Not Available | ||||||
CLN3 Double Nickase Plasmid (m2) | sc-419692-NIC-2 | 20 µg | $410.00 | |||
| Not Available | ||||||
CLN3 CRISPR Activation Plasmid (m) | sc-419692-ACT | 20 µg | $397.00 | |||
| Not Available | ||||||
CLN3 CRISPR Activation Plasmid (m2) | sc-419692-ACT-2 | 20 µg | $397.00 | |||
| Not Available | ||||||
CLN3 Lentiviral Activation Particles (m) | sc-419692-LAC | 200 µl | $455.00 | |||
| Not Available | ||||||
CLN3 Lentiviral Activation Particles (m2) | sc-419692-LAC-2 | 200 µl | $455.00 | |||
| Not Available | ||||||